Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP.

Urusova D, Carias L, Huang Y, Nicolete VC, Popovici J, Roesch C, Salinas ND, Witkowski B, Ferreira MU, Adams JH, Gross ML, King CL, Tolia NH.

Nat Microbiol. 2019 Sep;4(9):1486-1496. doi: 10.1038/s41564-019-0461-2. Epub 2019 May 27.

PMID:
31133752
2.

Identification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein.

Carias LL, Dechavanne S, Nicolete VC, Sreng S, Suon S, Amaratunga C, Fairhurst RM, Dechavanne C, Barnes S, Witkowski B, Popovici J, Roesch C, Chen E, Ferreira MU, Tolia NH, Adams JH, King CL.

J Immunol. 2019 May 1;202(9):2648-2660. doi: 10.4049/jimmunol.1801631. Epub 2019 Apr 3.

PMID:
30944159
3.

Plasmodium vivax transcriptomes reveal stage-specific chloroquine response and differential regulation of male and female gametocytes.

Kim A, Popovici J, Menard D, Serre D.

Nat Commun. 2019 Jan 22;10(1):371. doi: 10.1038/s41467-019-08312-z.

4.

Genetic diversity in two Plasmodium vivax protein ligands for reticulocyte invasion.

Roesch C, Popovici J, Bin S, Run V, Kim S, Ramboarina S, Rakotomalala E, Rakotoarison RL, Rasoloharimanana T, Andriamanantena Z, Kumar A, Guillotte-Blisnick M, Huon C, Serre D, Chitnis CE, Vigan-Womas I, Menard D.

PLoS Negl Trop Dis. 2018 Oct 22;12(10):e0006555. doi: 10.1371/journal.pntd.0006555. eCollection 2018 Oct.

5.

Recrudescence, Reinfection, or Relapse? A More Rigorous Framework to Assess Chloroquine Efficacy for Plasmodium vivax Malaria.

Popovici J, Pierce-Friedrich L, Kim S, Bin S, Run V, Lek D, Hee KHD, Lee Soon-U L, Cannon MV, Serre D, Menard D.

J Infect Dis. 2019 Jan 7;219(2):315-322. doi: 10.1093/infdis/jiy484.

PMID:
30102351
6.

Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.

Gupta S, Singh S, Popovici J, Roesch C, Shakri AR, Guillotte-Blisnick M, Huon C, Menard D, Chitnis CE.

Sci Rep. 2018 Jul 12;8(1):10511. doi: 10.1038/s41598-018-28757-4.

7.

Therapeutic and Transmission-Blocking 
Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia.

Popovici J, Vantaux A, Primault L, Samreth R, Piv EP, Bin S, Kim S, Lek D, Serre D, Menard D.

Emerg Infect Dis. 2018 Aug;24(8):1516-1519. doi: 10.3201/eid2408.170768. Epub 2018 Aug 17.

8.

Genomic Analyses Reveal the Common Occurrence and Complexity of Plasmodium vivax Relapses in Cambodia.

Popovici J, Friedrich LR, Kim S, Bin S, Run V, Lek D, Cannon MV, Menard D, Serre D.

MBio. 2018 Jan 23;9(1). pii: e01888-17. doi: 10.1128/mBio.01888-17.

9.

Antiplasmodial activities of dyes against Plasmodium falciparum asexual and sexual stages: Contrasted uptakes of triarylmethanes Brilliant green, Green S (E142), and Patent Blue V (E131) by erythrocytes.

Leba LJ, Popovici J, Estevez Y, Pelleau S, Legrand E, Musset L, Duplais C.

Int J Parasitol Drugs Drug Resist. 2017 Dec;7(3):314-320. doi: 10.1016/j.ijpddr.2017.07.002. Epub 2017 Aug 2.

10.

Characterization of P. vivax blood stage transcriptomes from field isolates reveals similarities among infections and complex gene isoforms.

Kim A, Popovici J, Vantaux A, Samreth R, Bin S, Kim S, Roesch C, Liang L, Davies H, Felgner P, Herrera S, Arévalo-Herrera M, Ménard D, Serre D.

Sci Rep. 2017 Aug 10;7(1):7761. doi: 10.1038/s41598-017-07275-9.

11.

Plasmodium vivax Malaria in Cambodia.

Siv S, Roca-Feltrer A, Vinjamuri SB, Bouth DM, Lek D, Rashid MA, By NP, Popovici J, Huy R, Menard D.

Am J Trop Med Hyg. 2016 Dec 28;95(6 Suppl):97-107. doi: 10.4269/ajtmh.16-0208. Epub 2016 Oct 5.

12.

National Malaria Prevalence in Cambodia: Microscopy Versus Polymerase Chain Reaction Estimates.

Lek D, Popovici J, Ariey F, Vinjamuri SB, Meek S, Bruce J, Taylor WR, Socheat D, Menard D, Rogers WO.

Am J Trop Med Hyg. 2016 Sep 7;95(3):588-94. doi: 10.4269/ajtmh.15-0908. Epub 2016 Jul 11.

13.

Complexity of Infection and Genetic Diversity in Cambodian Plasmodium vivax.

Friedrich LR, Popovici J, Kim S, Dysoley L, Zimmerman PA, Menard D, Serre D.

PLoS Negl Trop Dis. 2016 Mar 28;10(3):e0004526. doi: 10.1371/journal.pntd.0004526. eCollection 2016 Mar.

14.

Applicability of UV resistant Bacillus pumilus endospores as a human adenovirus surrogate for evaluating the effectiveness of virus inactivation in low-pressure UV treatment systems.

Boczek LA, Rhodes ER, Cashdollar JL, Ryu J, Popovici J, Hoelle JM, Sivaganesan M, Hayes SL, Rodgers MR, Ryu H.

J Microbiol Methods. 2016 Mar;122:43-9. doi: 10.1016/j.mimet.2016.01.012. Epub 2016 Jan 26.

PMID:
26825005
15.

Challenges in Antimalarial Drug Treatment for Vivax Malaria Control.

Popovici J, Ménard D.

Trends Mol Med. 2015 Dec;21(12):776-788. doi: 10.1016/j.molmed.2015.10.004. Epub 2015 Nov 21. Review.

PMID:
26611336
16.

Field evaluation of the establishment potential of wMelPop Wolbachia in Australia and Vietnam for dengue control.

Nguyen TH, Nguyen HL, Nguyen TY, Vu SN, Tran ND, Le TN, Vien QM, Bui TC, Le HT, Kutcher S, Hurst TP, Duong TT, Jeffery JA, Darbro JM, Kay BH, Iturbe-Ormaetxe I, Popovici J, Montgomery BL, Turley AP, Zigterman F, Cook H, Cook PE, Johnson PH, Ryan PA, Paton CJ, Ritchie SA, Simmons CP, O'Neill SL, Hoffmann AA.

Parasit Vectors. 2015 Oct 28;8:563. doi: 10.1186/s13071-015-1174-x.

17.

Use of Plasmodium falciparum culture-adapted field isolates for in vitro exflagellation-blocking assay.

Leba LJ, Musset L, Pelleau S, Estevez Y, Birer C, Briolant S, Witkowski B, Ménard D, Delves MJ, Legrand E, Duplais C, Popovici J.

Malar J. 2015 Jun 4;14:234. doi: 10.1186/s12936-015-0752-x.

18.

Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti.

Ferguson NM, Kien DT, Clapham H, Aguas R, Trung VT, Chau TN, Popovici J, Ryan PA, O'Neill SL, McGraw EA, Long VT, Dui le T, Nguyen HL, Chau NV, Wills B, Simmons CP.

Sci Transl Med. 2015 Mar 18;7(279):279ra37. doi: 10.1126/scitranslmed.3010370.

19.

Discovery of putative small non-coding RNAs from the obligate intracellular bacterium Wolbachia pipientis.

Woolfit M, Algama M, Keith JM, McGraw EA, Popovici J.

PLoS One. 2015 Mar 4;10(3):e0118595. doi: 10.1371/journal.pone.0118595. eCollection 2015.

20.

Reduced polymorphism in the Kelch propeller domain in Plasmodium vivax isolates from Cambodia.

Popovici J, Kao S, Eal L, Bin S, Kim S, Ménard D.

Antimicrob Agents Chemother. 2015 Jan;59(1):730-3. doi: 10.1128/AAC.03908-14. Epub 2014 Nov 10.

21.

Effects of mefloquine use on Plasmodium vivax multidrug resistance.

Khim N, Andrianaranjaka V, Popovici J, Kim S, Ratsimbasoa A, Benedet C, Barnadas C, Durand R, Thellier M, Legrand E, Musset L, Menegon M, Severini C, Nour BY, Tichit M, Bouchier C, Mercereau-Puijalon O, Ménard D.

Emerg Infect Dis. 2014 Oct;20(10):1637-44. doi: 10.3201/eid2010.140411.

22.

Endospore surface properties of commonly used Bacillus anthracis surrogates vary in aqueous solution.

White CP, Popovici J, Lytle DA, Rice EW.

Antonie Van Leeuwenhoek. 2014 Aug;106(2):243-51. doi: 10.1007/s10482-014-0187-3. Epub 2014 May 11.

PMID:
24817579
23.

Characterization of the cell surface properties of drinking water pathogens by microbial adhesion to hydrocarbon and electrophoretic mobility measurements.

Popovici J, White CP, Hoelle J, Kinkle BK, Lytle DA.

Colloids Surf B Biointerfaces. 2014 Jun 1;118:126-32. doi: 10.1016/j.colsurfb.2014.03.033. Epub 2014 Mar 28.

PMID:
24815929
24.

Limited dengue virus replication in field-collected Aedes aegypti mosquitoes infected with Wolbachia.

Frentiu FD, Zakir T, Walker T, Popovici J, Pyke AT, van den Hurk A, McGraw EA, O'Neill SL.

PLoS Negl Trop Dis. 2014 Feb 20;8(2):e2688. doi: 10.1371/journal.pntd.0002688. eCollection 2014 Feb.

25.

Assessing quality of life-shortening Wolbachia-infected Aedes aegypti mosquitoes in the field based on capture rates and morphometric assessments.

Yeap HL, Axford JK, Popovici J, Endersby NM, Iturbe-Ormaetxe I, Ritchie SA, Hoffmann AA.

Parasit Vectors. 2014 Feb 3;7:58. doi: 10.1186/1756-3305-7-58.

26.

Genomic evolution of the pathogenic Wolbachia strain, wMelPop.

Woolfit M, Iturbe-Ormaetxe I, Brownlie JC, Walker T, Riegler M, Seleznev A, Popovici J, Rancès E, Wee BA, Pavlides J, Sullivan MJ, Beatson SA, Lane A, Sidhu M, McMeniman CJ, McGraw EA, O'Neill SL.

Genome Biol Evol. 2013;5(11):2189-204. doi: 10.1093/gbe/evt169.

27.

The toll and Imd pathways are not required for wolbachia-mediated dengue virus interference.

Rancès E, Johnson TK, Popovici J, Iturbe-Ormaetxe I, Zakir T, Warr CG, O'Neill SL.

J Virol. 2013 Nov;87(21):11945-9. doi: 10.1128/JVI.01522-13. Epub 2013 Aug 28.

28.

Infection with a Virulent Strain of Wolbachia Disrupts Genome Wide-Patterns of Cytosine Methylation in the Mosquito Aedes aegypti.

Ye YH, Woolfit M, Huttley GA, Rancès E, Caragata EP, Popovici J, O'Neill SL, McGraw EA.

PLoS One. 2013 Jun 19;8(6):e66482. doi: 10.1371/journal.pone.0066482. Print 2013.

29.

Effect of pH on the electrophoretic mobility of spores of Bacillus anthracis and its surrogates in aqueous solutions.

White CP, Popovici J, Lytle DA, Adcock NJ, Rice EW.

Appl Environ Microbiol. 2012 Dec;78(23):8470-3. doi: 10.1128/AEM.01337-12. Epub 2012 Sep 21.

30.

Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission.

Hoffmann AA, Montgomery BL, Popovici J, Iturbe-Ormaetxe I, Johnson PH, Muzzi F, Greenfield M, Durkan M, Leong YS, Dong Y, Cook H, Axford J, Callahan AG, Kenny N, Omodei C, McGraw EA, Ryan PA, Ritchie SA, Turelli M, O'Neill SL.

Nature. 2011 Aug 24;476(7361):454-7. doi: 10.1038/nature10356.

PMID:
21866160
31.

An allelochemical from Myrica gale with strong phytotoxic activity against highly invasive Fallopia x bohemica taxa.

Popovici J, Bertrand C, Jacquemoud D, Bellvert F, Fernandez MP, Comte G, Piola F.

Molecules. 2011 Mar 10;16(3):2323-33. doi: 10.3390/molecules16032323.

32.

Assessing key safety concerns of a Wolbachia-based strategy to control dengue transmission by Aedes mosquitoes.

Popovici J, Moreira LA, Poinsignon A, Iturbe-Ormaetxe I, McNaughton D, O'Neill SL.

Mem Inst Oswaldo Cruz. 2010 Dec;105(8):957-64.

33.

Differential effects of rare specific flavonoids on compatible and incompatible strains in the Myrica gale-Frankia actinorhizal symbiosis.

Popovici J, Comte G, Bagnarol E, Alloisio N, Fournier P, Bellvert F, Bertrand C, Fernandez MP.

Appl Environ Microbiol. 2010 Apr;76(8):2451-60. doi: 10.1128/AEM.02667-09. Epub 2010 Feb 26.

34.

Chemical composition of essential oil and headspace-solid microextracts from fruits of Myrica gale L. and antifungal activity.

Popovici J, Bertrand C, Bagnarol E, Fernandez MP, Comte G.

Nat Prod Res. 2008;22(12):1024-32. doi: 10.1080/14786410802055568.

PMID:
18780242

Supplemental Content

Loading ...
Support Center